On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

e-Therapeutics (United Kingdom)

InstitutionResearch output, impact & collaborations

e-Therapeutics (United Kingdom) is a institution indexed in ScholarIQ from OpenAlex.

What is known about e-Therapeutics (United Kingdom)?

ScholarIQrecord summary

e-Therapeutics (United Kingdom) is a research organisation in Witney, GB. OpenAlex records 215 works and 11,022 citations for it. 126 researchers list it as their most recent affiliation.

How many works does e-Therapeutics (United Kingdom) have?

ScholarIQindexed works

e-Therapeutics (United Kingdom) has 215 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does e-Therapeutics (United Kingdom) have?

ScholarIQcitation count

e-Therapeutics (United Kingdom) has 11,022 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at e-Therapeutics (United Kingdom)?

ScholarIQresearcher count

e-Therapeutics (United Kingdom) has 126 researchers in the ScholarIQ index.

What is the average h-index at e-Therapeutics (United Kingdom)?

ScholarIQavg h-index

e-Therapeutics (United Kingdom) has an average h-index of 49.5 in OpenAlex.

What is the ROR of e-Therapeutics (United Kingdom)?

ScholarIQror

The ROR for e-Therapeutics (United Kingdom) is on the source record.

What is the OpenAlex record for e-Therapeutics (United Kingdom)?

ScholarIQopenalex

The OpenAlex for e-Therapeutics (United Kingdom) is on the source record.

Who are the most-cited researchers behind e-Therapeutics (United Kingdom)?

ScholarIQtop researchers by citations
1
James Taylor · Scientific Computing and Data Management
218 works52,632 citations
2
John R. Pollard · DNA Repair Mechanisms
161 works16,159 citations

What are the most-cited papers on e-Therapeutics (United Kingdom)?

ScholarIQmost cited works
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy
Robert S. Fisher, Vicenta Salanova, Thomas C. Witt, Robert M. Worth, Thomas R. Henry, Robert E. Gross, Kalarickal J. Oommen, Ivan Osorio, Jules M. Nazzaro, Douglas Labar, Michael G. Kaplitt, Michael R. Sperling, Evan Sandok, John H. Neal, Adrian Handforth, John M. Stern, Antonio A. F. DeSalles, Steve Chung, Andrew G. Shetter, Donna Bergen, Roy A.E. Bakay, Jaimie M. Henderson, Jacqueline A. French, Gordon H. Baltuch, William E. Rosenfeld, Andrew Youkilis, William J. Marks, Paul A. Garcia, N. M. Barbaro, Nathan B. Fountain, Carl W. Bazil, Robert Goodman, Guy M. McKhann, K.B. Krishnamurthy, Steven Papavassiliou, Charles M. Epstein, John R. Pollard, Lisa Tonder, Joan Grebin, Robert J. Coffey, Nina M. Graves, the SANTE Study Group
Epilepsia. 20101,939 Citations
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
Vicenta Salanova, Thomas J. Witt, Robert M. Worth, Thomas R. Henry, Robert E. Gross, Jules M. Nazzaro, Douglas Labar, Michael R. Sperling, Ashwini Sharan, Evan Sandok, Adrian Handforth, John M. Stern, Steve Chung, Jaimie M. Henderson, Jacqueline A. French, Gordon H. Baltuch, William E. Rosenfeld, Paul A. Garcia, Nicholas M. Barbaro, Nathan B. Fountain, W. Jeffrey Elias, Robert Goodman, John R. Pollard, Alexander I. Tröster, Christopher P. Irwin, Kristin Lambrecht, Nina M. Graves, Robert S. Fisher, For the SANTE Study Group, Charles M. Epstein, Jeanne King, Ivan Osorio, Roy A.E. Bakay, Donna Bergen
Neurology. 2015836 CitationsOPEN ACCESS
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui‐Chien Kuo, Alexander Marx, Philipp Ströbel, Claudio Mazia, Joël Oger, Gabriel Cea, Jeannine M. Heckmann, Amelia Evoli, Wilfred A. Nix, Emma Ciafaloni, Giovanni Antonini, Rawiphan Witoonpanich, John King, Said R. Beydoun, Colin Chalk, Alexandru Barboi, Anthony A. Amato, Aziz Shaibani, Bashar Katirji, Bryan Lecky, Camilla Buckley, Angela Vincent, Elza Dias‐Tosta, Hiroaki Yoshikawa, Márcia Waddington‐Cruz, Michael Pulley, Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Nicholas J. Silvestri, Robin Conwit, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter, Gary Cutter, Inmaculada Aban, Greg Minisman, Michelle Feese, Hui‐Chien Kuo, John Newsom–Davis, Gil I. Wolfe, Henry J. Kaminski, Alfred Jaretzki, Joshua Sonett, Claudio Mazia, Valeria Saluto, Moisés Rosenberg, Valeria Alvarez, Lisa A. Rocca Rey, John King, Helmut Butzkueven, John Goldblatt, John C. Carey, John R. Pollard, Stephen Reddel, Nicholas Handel, Brian C. McCaughan, Linda Pallot, Márcia Waddington‐Cruz, Ricardo Novis, Carlos Henrique Ribeiro Boasquevisque, Elza Dias‐Tosta, Rubens N. Morato-Fernandez, Manoel Ximenes, Lineu César Werneck, Rosana Hermínia Scola, Paulo Soltoski, Colin Chalk, Fraser Moore, David S. Mulder, Lisa Wadup, Joël Oger, Michele Mezei, Kenneth G. Evans, Theresa Jiwa, Anne Schaffar, Chris White, Cory Toth, Gary Gelfand, Susan P. Wood, Elizabeth Pringle, Jocelyn Zwicker, Donna E. Maziak, Farid M. Shamji, Sudhir Sundaresan, Andrew Seely
The Lancet Neurology. 2019225 CitationsOPEN ACCESS

How much of the research on e-Therapeutics (United Kingdom) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
33%
Bronze
0%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial